AI could check millions of CT scans for heart risk. Who will pay for it?

Screening algorithms could flag undetected risk — and unleash a flood of billable follow-up care. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

April 18, 2026 Check out STAT+

Sponsored By

Three-letter part of a maple tree that becomes syrup? Play the latest STAT Mini crossword!

STAT/Adobe STAT+ | AI could check millions of CT scans for heart risk. Who will pay for it? Millions of routine CT scans hold clues to heart disease risk. Should a new Medicare payment pathway speed the adoption of AI-based coronary calcium screening? By Katie Palmer Adobe STAT+ | Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target A provocative new study suggests that mechanisms other than GLP-1 could cause weight loss without side effects. By Elaine Chen Opinion: Hosting the ‘intellectual wrestling match’ between MAHA, public health On the 'First Opinion Podcast,' Brinda Adhikari and Tom W. Johnson bring together MAHA and public health for real conversations. By Torie Bosch STAT+ | Hospitals roll out chatbots, looking to reclaim their role in patients’ health conversations A handful of hospitals across the country are launching their own chatbots, a risky bet aimed at better serving current patients and gaining new ones. By Katie Palmer STAT+ | Flawed study on the antidepressant Paxil came with a cautionary note — if you knew how to find it Study on the antidepressant Paxil now carries an 'expression of concern' that it's under review for possible retraction. The notice is not easy to find. By Ed Silverman A top WHO official confronts Iran war fallout, and weighs bid for an even bigger role Balkhy, director of the World Health Organization’s eastern Mediterranean region, may run for WHO director-general. The Iran war is complicating her decision. By Helen Branswell STAT+ | Cell therapy primed liver transplant patients to avoid organ rejection, small study shows Cells from living donors were injected into patients before the transplant to prime their immune system to accept the new organ with less immunosuppression. By Elizabeth Cooney STAT+ | Opinion: Landmines await Vinay Prasad’s successor at the FDA Lacking political savvy pretty much doomed Vinay Prasad at the FDA. His successor will have to make tough choices. By Paul Knoepfler

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser